The New Mexico Department of Health encourages oral COVID-19 treatment options for those who are at high risk for developing severe symptoms of the virus, according to a press release from NMDOH.
The release said COVID-19 can be very serious for people with health conditions, and there’s a limited window to start treatment.
Oral treatment options include Paxlovid for people ages 12 and up and Molnupiravir for people ages 18 and up.
There’s also IV treatment options like Remdesivir and Sotrovimab. Those ages 12 and up are eligible to be treated with Sotrovimab, per the release.
Oral treatments would start within five days after the onset of symptoms, while IV treatments would start within seven to 10 after symptoms develop.
One should get tested for COVID-19 if their symptoms include cough, fever, shortness of breath, chills, muscle pain, headache, sore throat, runny nose, nausea, diarrhea or a loss of taste or smell.
If one does not have insurance through a medical provider, they can call NMDOH’s COVID-19 hotline at 1-855-600-3453.
